Grifols Laredo

Grifols Laredo Grifols mission is to improve the health and well-being of people around the world. We look forward to your visit!
(138)

Grifols prides itself on donor safety, the safety of our plasma, and the difference we make together--in the lives of patients around the world, in our communities, and in the industry. We specialize in the collection of protein-rich plasma from donors to help create life-saving therapies for patients with diseases, such as immune deficiencies, hemophilia, genetic emphysema, hepatitis, tetanus and

rabies. We encourage donors to donate on a routine basis, and we compensate them for their time. As a Grifols plasma donor, your comfort and safety are our number one priority. After all, it's your donations that make our life-changing medications possible.

Address

815 Grant Street
Laredo, TX
78040

Opening Hours

Monday 7am - 6pm
Tuesday 7am - 7pm
Wednesday 7am - 7pm
Thursday 7am - 7pm
Friday 7am - 7pm
Saturday 7am - 4pm
Sunday 7am - 4pm

Telephone

+19567297677

Alerts

Be the first to know and let us send you an email when Grifols Laredo posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

About Us

GCAM Plasma Laredo, TX is one of GCAM, Inc.’s many plasma centers located across the U.S. GCAM is dedicated to and specializes in the plasma industry. Our facilities are licensed and regulated by the Food and Drug Administration (FDA).

Our centers pride themselves in collecting quality plasma in a pleasant and relaxing environment. Our primary focus is donor safety and satisfaction. We consider our donors to be "STARS"​ through the simple process of donating plasma they are making an important commitment to their communities and help save lives throughout the world.

As a facility approved by the Food and Drug Administration, we must adhere to strict eligibility guidelines to ensure safety for both our donors and the patients receiving the plasma-derived medications and therapies.

General Eligibility Guidelines: